Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Saikesaisi Medical Technology is a prominent Chinese medical device company focused on the research, development, and manufacturing of high-end absorbable biomaterials. The company specializes in products for surgical hemostasis, tissue sealing, adhesion prevention, and interventional embolization, serving a wide range of clinical departments including general surgery, neurosurgery, and cardiology. Its core product line includes absorbable hemostatic gauze, medical chitosan dressings, and hydrogel-based sealants designed to improve surgical outcomes and patient recovery. Saikesaisi Medical leverages its expertise in polymer science to maintain a robust pipeline of innovative medical consumables and interventional devices. The company is recognized as a leader in the domestic Chinese market for bio-absorbable materials and continues to expand its international footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Saikesaisi Medical.